Guru Gobind Singh College of Pharmacy, Yamuna Nagar, 135001, Haryana, India.
Infect Disord Drug Targets. 2023;23(6):e270423216271. doi: 10.2174/1871526523666230427115436.
Hemorrhoid disease (HD) is an anal-rectal ailment that is commonly painful or may be painless and causes rectal bleeding with or without prolapsing anal tissue. It is generally associated with bleeding, prolapse, pruritus, and discomfort, which results in a diminished quality of life and well-being.
To highlight the recent developments in terms of safety, clinical efficacy, and marketed formulation for the effective management of hemorrhoids.
Reported literature available on Scopus, PubMed, Science Direct, Clinicaltrails.gov, and from many reputed foundations has been studied to summarize the recent development and clinical studies for the management of hemorrhoids.
The high incidence of hemorrhoids obliges the development of new molecules; therefore, safe and efficient drugs to confer protection against hemorrhoids are urgently needed. This review article mainly focuses on the newer molecules to overcome hemorrhoids and also emphasizes various studies carried out in the past.
痔病(HD)是一种肛门直肠疾病,通常伴有疼痛,也可能无疼痛,并伴有或不伴有脱垂的肛门组织出现直肠出血。它通常与出血、脱垂、瘙痒和不适有关,导致生活质量和幸福感下降。
强调在安全、临床疗效和市售制剂方面的最新进展,以有效管理痔病。
研究了 Scopus、PubMed、Science Direct、Clinicaltrails.gov 以及许多知名基金会上可用的报告文献,以总结痔病管理的最新发展和临床研究。
痔病的高发率促使新分子的开发;因此,迫切需要安全有效的药物来预防痔病。这篇综述文章主要关注克服痔病的新分子,并强调过去进行的各种研究。